Progress of immune checkpoint inhibitors in treatment of hematologic malignancies / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 1-2,11, 2017.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-606018
Biblioteca responsável:
WPRO
ABSTRACT
In recent years, immunotherapy has become an indispensable part in treatment of cancer, and the immune checkpoint inhibitors are the focus of attention. In the 58th American Society of Hematology (ASH) Annual Meeting, the application of immune checkpoint inhibitors in hematologic malignancies had been widely concerned. The recent progress of immune checkpoint inhibitors in hematologic malignancies in this annual meeting will be briefly introduced.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2017
Tipo de documento:
Artigo